Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis
T Bellnier, GW Brown, TR Ortega - Mental Health Clinician, 2018 - meridian.allenpress.com
Introduction: Medical cannabis (MC) is commonly claimed to be an effective treatment for
chronic or refractory pain. With interest in MC in the United States growing, as evidenced by …
chronic or refractory pain. With interest in MC in the United States growing, as evidenced by …
Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain
TL Burns, JR Ineck - Annals of Pharmacotherapy, 2006 - journals.sagepub.com
Objective: To review the literature concerning the physiology of the endocannabinoid
system, current drug development of cannabinoid agonists, and current clinical research on …
system, current drug development of cannabinoid agonists, and current clinical research on …
[HTML][HTML] Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside
EJ Rahn, AG Hohmann - Neurotherapeutics, 2009 - Elsevier
Neuropathic pain is a debilitating form of chronic pain resulting from nerve injury, disease
states, or toxic insults. Neuropathic pain is often refractory to conventional …
states, or toxic insults. Neuropathic pain is often refractory to conventional …
[HTML][HTML] Cannabinoids in pain management and palliative medicine: An overview of systematic reviews and prospective observational studies
W Häuser, MA Fitzcharles, L Radbruch… - Deutsches Ärzteblatt …, 2017 - ncbi.nlm.nih.gov
Background There are conflicting interpretations of the evidence regarding the efficacy,
tolerability, and safety of cannabinoids in pain management and palliative medicine …
tolerability, and safety of cannabinoids in pain management and palliative medicine …
Efficacy and adverse effects of medical marijuana for chronic noncancer pain: systematic review of randomized controlled trials
A Deshpande, A Mailis-Gagnon, N Zoheiry… - Canadian Family …, 2015 - cfp.ca
Objective To determine if medical marijuana provides pain relief for patients with chronic
noncancer pain (CNCP) and to determine the therapeutic dose, adverse effects, and specific …
noncancer pain (CNCP) and to determine the therapeutic dose, adverse effects, and specific …
[HTML][HTML] Cannabis in pain treatment: clinical and research considerations
SR Savage, A Romero-Sandoval, M Schatman… - The Journal of …, 2016 - Elsevier
Cannabinoids show promise as therapeutic agents, particularly as analgesics, but their
development and clinical use has been complicated by recognition of their botanical source …
development and clinical use has been complicated by recognition of their botanical source …
[HTML][HTML] Medical cannabis for chronic nonmalignant pain management
Abstract Purpose of Review Cannabis has been used since ancient times for medical and
recreational research. This review article will document the validity of how medical cannabis …
recreational research. This review article will document the validity of how medical cannabis …
Systematic review of systematic reviews for medical cannabinoids: Pain, nausea and vomiting, spasticity, and harms
GM Allan, CR Finley, J Ton, D Perry, J Ramji… - Canadian Family …, 2018 - cfp.ca
Objective To determine the effects of medical cannabinoids on pain, spasticity, and nausea
and vomiting, and to identify adverse events. Data sources MEDLINE, the Cochrane …
and vomiting, and to identify adverse events. Data sources MEDLINE, the Cochrane …
Availability and approval of cannabis‐based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of …
N Krcevski‐Skvarc, C Wells… - European Journal of …, 2018 - Wiley Online Library
Background There is considerable public and political interest in the use of cannabis
products for medical purposes. Methods The task force of the European Pain Federation …
products for medical purposes. Methods The task force of the European Pain Federation …
[HTML][HTML] Dronabinol is a safe long-term treatment option for neuropathic pain patients
S Schimrigk, M Marziniak, C Neubauer, EM Kugler… - European …, 2017 - karger.com
Abstract Treatment of neuropathic pain (NP) symptoms associated with multiple sclerosis
(MS) is frequently insufficient. Yet, cannabis is still rarely offered for treatment of pain. This …
(MS) is frequently insufficient. Yet, cannabis is still rarely offered for treatment of pain. This …